Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

• by Esther Ganelin-Cohen, Yair Wexler, Sraya Kraus, Ayal Rozenberg

• May 1, 2026

Forecasting Surgical Duration in Pediatric Urology Using a Deep Learning Model That Integrates Multimodal Patient and Physician Data

• by Yonggen Zhao, Ruoge Lin, Yiying Sun, Lingdong Chen, Jian Huang, Guangjie Chen, Zhu Zhu, Gang Yu

• April 28, 2026

Pediatric meningoencephalitis in the molecular diagnostic era: epidemiological insights from 1198 suspected cases in Germany between 2016 and 2024

• by Yannik Vollmuth, Benjamin Soric, Jana Beer, Uta Behrends, Marco Paolini, Astrid Blaschek, Melanie Meyer-Bühn, Christoph Klein, Johannes Hübner, Gerhard Dobler, Tilmann Schober

• May 4, 2026

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS

• February 17, 2026

• 3 min